Research reveals close similarity among Lassa virus strains, boosting vaccine development prospects for Nigeria and beyond.
Prof. Alash’le Abimiku of the IRCE says studies show minor variations but overall similarity in Lassa virus strains across Nigeria, offering promise for a unified vaccine to combat the disease in West Africa. With over 857 confirmed cases and 160 deaths so far in 2025, largely affecting young adults, Lassa fever remains a critical health threat. Ongoing vaccine trials in Nigeria and neighboring countries could transform prevention, while research continues despite funding challenges.
Leave a comment